Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 3

Status

Completed 4

Sponsor Class

NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 10Lymphoid 5Gastrointestinal 4Genitourinary 3Gynecologic 2Sarcoma 1Plasma cell 1Head & Neck 1Dermatologic 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × alvocidib × Gastrointestinal × Clear all
NCT00331682 2014-05-28

Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
10 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00991952 2014-05-26

Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 2 Completed
19 enrolled 8 charts
Gastrointestinal

Stomach Neoplasms

NCT00006245 2013-06-24

Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel

National Cancer Institute (NCI)

Phase 2 Completed
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00087282 2013-06-24

Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡